Navigation Links
Gastroenterology special issue focuses on new directions of viral hepatitis care and research
Date:5/15/2012

The editors of Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute, are pleased to announce the publication of this year's highly anticipated special 13th issue. Published each May, the 13th issue is devoted to a particular gastroenterological topic of broad interest; this year's topic is viral hepatitis.

In conjunction with editor-in-chief M. Bishr Omary, MD, PhD, this issue was developed by Gastroenterology's experts in viral hepatitis: Senior Associate Editor Anna S. Lok, MD, AGAF, and Associate Editor Jean-Michel Pawlotsky, MD, PhD. Their expertise guided the contributing authors an outstanding group of thoughtful expert international leaders.

"Our goals in this special issue of Gastroenterology are to give readers an up-to-date insight into the tremendous progress made over the past few years in viral hepatitis research and care, and to guide them through complex challenges and expected future developments," said the editors.

In this year's issue, classic review articles are interspersed with insightful commentaries that address critical unresolved issues and fundamental questions for the future. The content is organized into four sections, mainly related to hepatitis B virus and hepatitis C virus (HCV) infections: epidemiology and pathophysiology; diagnostic and prognostic tools; therapy and prevention; and hepatitis E virus, a neglected virus that was recently found to be clinically important in industrialized countries.

No other field in hepatology and gastroenterology has grown more rapidly than viral hepatitis in the past 15 years, thanks to the considerable interest of the scientific community for diseases that involve more than 500 million patients worldwide; active support for research from governments in the U.S., Europe, Japan and Australia; and major drug industry investment for what promises to be an incredibly rewarding market for antiviral drugs. This issue not only contains classical review articles dealing with important areas for which major advances have occurred recently, but editorial-like commentaries exploring critical unresolved issues and fundamental questions for the future. The commentaries, reviews and their distinguished authors are as follows:

Commentaries

  • "Is Hepatitis C Virus Carcinogenic?" by Stanley M. Lemon and David R. McGivern
  • "HCV Infection and Metabolic Syndrome: Which Is the Chicken and Which Is the Egg?" by Francesco Negro
  • "Genetic Factors and Hepatitis C Virus Infection" by Alexander J. Thompson
  • "Will Interferon-Free Regimens Prevail?" by Christoph Welsch and Stefan Zeuzem
  • "Is There a Role for Ribavirin in the Era of Hepatitis C Virus Direct-Acting Antivirals?" by Jordan J. Feld
  • "Is Hepatitis Virus Resistance to Antiviral Drugs a Threat?" by Jean-Michel Pawlotsky
  • "Will There Be a Vaccine to Protect Against the Hepatitis C Virus?" by Benot Callendret and Christopher M. Walker

Reviews

  • "Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma" by Hashem B. El-Serag
  • "Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease" by Jens Bukh
  • "Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C" by Laurent Castera
  • "New Virologic Tools for Management of Chronic Hepatitis B and C" by Stphane Chevaliez, Christophe Rodriguez and Jean-Michel Pawlotsky
  • "Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus" by A. Sidney Barritt and Michael W. Fried
  • "Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals" by Susanna Naggie and Mark S. Sulkowski
  • "Anti-Hepatitis C Virus Drugs in Development" by Esperance A.K. Schaefer and Raymond T. Chung
  • "Effectiveness of Hepatitis B Treatment in Clinical Practice" by Steven J. Scaglione and Anna S.F. Lok
  • "Viral Hepatitis in Liver Transplantation" by Gonzalo Crespo, Zoe Mario, Miquel Navasa and Xavier Forns
  • "Pathogenesis and Treatment of Hepatitis E Virus Infection" by Heiner Wedemeyer, Sven Pischke and Michael P. Manns

"We hope this supplementary issue will provide the readers with useful and up-to-date information to understand the new directions of viral hepatitis care and research, and the formidable remaining challenges," stated Drs. Lok and Pawlotsky.


'/>"/>

Contact: Alissa J. Cruz
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. Unique gastroenterology procedure developed in adults shows promise in pediatrics
2. Arab Journal of Gastroenterology accepted for MEDLINE indexing
3. Product Innovators Launch Unique Sensory Tool for Special Needs Youth
4. Multi-Award Winning Author Tina Turbin Interviews Special Guest Dr. Peter H.R. Green, M.D. On The Thrive in Balance Radio Show
5. Solutions for Sleep Problems: Harvard's Improving Sleep Special Health Report and New Sleep Apnea Video
6. Orthopaedic Physician Dr. Brett Smith Joins Baptist Health Care as Total Joint Specialist
7. Quitting smoking especially difficult for select groups
8. Kars4Kids and Newark Beth Israel Distribute Special Gifts at Children's Hospital
9. Special Olympics Georgia Receives Grant from The Home Depot Foundation
10. Special issue of NeuroRehabilitation focuses on hypoxic-ischemic brain injuries
11. Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... ... technology-enabled services supporting clinical research, today announces that 30 of its domain ... the drug development lifecycle at upcoming industry conferences and webinars. Drawing on ...
(Date:9/25/2017)... ... September 25, 2017 , ... Earlypicker is expanding its offerings ... shop for the hottest Korean cosmetics and fashion trends sweeping the nation. The decision ... already well-known for the great offerings that allow Koreans everywhere to look their best ...
(Date:9/25/2017)... , ... September 25, 2017 , ... “The Majestic Unicorn”: ... the great flood. “The Majestic Unicorn” is the creation of published author, Dayna Chantel, ... small, came from far and wide to march aboard the cypress ark-vessel. Male and ...
(Date:9/25/2017)... Philadelphia, PA (PRWEB) , ... September 25, 2017 , ... Emerald Ash Borers ... pest's destruction can be seen throughout the Philadelphia region. A video by Rob Nagy, ... is lined with Ash trees. While several are dead or showing signs of decline ...
(Date:9/24/2017)... ... ... Throughout the United States and the world, clinicians take a simple but ... providers work to give the best care possible to patients and communities, while seeking ... are threatening to tie our hands in carrying out that oath. The Graham-Cassidy legislation ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 2017 ... coming to Washington DC ... Tuesday, September 12 th – Monday, September 18 th .The Brain ... MRI brain scans to the public.Where:  BTF,s Mobile ... 501 K Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the Road ...
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... -- For nearly two decades, New Life Agency has been committed to providing ... New Life Agency announces a powerful three-way partnership designed to deliver substantial ... ... http://www.schrafts2.com/ ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
Breaking Medicine Technology: